William R Hiatt

William R Hiatt

UNVERIFIED PROFILE

Are you William R Hiatt?   Register this Author

Register author
William R Hiatt

William R Hiatt

Publications by authors named "William R Hiatt"

Are you William R Hiatt?   Register this Author

100Publications

2541Reads

17Profile Views

Impact of Procedural Bleeding in Peripheral Artery Disease: An Analysis From EUCLID Trial.

Circ Cardiovasc Interv 2019 Oct 4;12(10):e008069. Epub 2019 Oct 4.

Division of Cardiology, Duke Heart Center (A.K., M.R.P., S.J.), Duke University, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCINTERVENTIONS.119.008069DOI Listing
October 2019

Lost in translation: Why 'lost to follow-up' matters.

Vasc Med 2019 08 13;24(4):339-340. Epub 2019 Jun 13.

1 Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1358863X19853623DOI Listing
August 2019

Acute Limb Ischemia in Peripheral Artery Disease.

Circulation 2019 Aug 26;140(7):556-565. Epub 2019 Jun 26.

Division of Cardiology, Department of Medicine, University of Colorado School of Medicine and CPC Clinical Research, Aurora (C.N.H., W.R.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.119.039773DOI Listing
August 2019

Heterogeneity of Risk and Benefit in Subgroups of COMPASS: Relatively Similar But Absolutely Different.

J Am Coll Cardiol 2019 Jul;73(25):3292-3294

University of Colorado School of Medicine, Department of Medicine, Division of Cardiology, and CPC Clinical Research, Aurora, Colorado. Electronic address: https://twitter.com/MarcBonaca.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2019.05.007DOI Listing
July 2019

Stroke in Patients With Peripheral Artery Disease.

Stroke 2019 Jun 16;50(6):1356-1363. Epub 2019 May 16.

Division of Cardiology, Department of Medicine (W.S.J., M.R.P.), Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/STROKEAHA.118.023534DOI Listing
June 2019

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study.

Am Heart J 2018 12 29;206:80-93. Epub 2018 Sep 29.

Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Division of Cardiovascular Medicine Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00028703183028
Publisher Site
http://dx.doi.org/10.1016/j.ahj.2018.09.011DOI Listing
December 2018

Behavior-Change Intervention Targeting Physical Function, Walking, and Disability After Dysvascular Amputation: A Randomized Controlled Pilot Trial.

Arch Phys Med Rehabil 2018 11 7;99(11):2160-2167. Epub 2018 May 7.

Department of Physical Medicine and Rehabilitation, Physical Therapy Program, University of Colorado, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.apmr.2018.04.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215727PMC
November 2018

Guideline-directed statin intensification in patients with new or worsening symptoms of peripheral artery disease.

Clin Cardiol 2018 Nov 19;41(11):1414-1422. Epub 2018 Oct 19.

Department of Cardiovascular Outcomes Research, Saint Luke's Mid America Heart Institute, Kansas City, Missouri.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/clc.23087
Publisher Site
http://dx.doi.org/10.1002/clc.23087DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489902PMC
November 2018

Cardiovascular Outcomes After Lower Extremity Endovascular or Surgical Revascularization: The EUCLID Trial.

J Am Coll Cardiol 2018 10;72(14):1563-1572

Division of Cardiology and CPC Clinical Research, University of Colorado School of Medicine, Aurora, Colorado. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S07351097183574
Publisher Site
http://dx.doi.org/10.1016/j.jacc.2018.07.046DOI Listing
October 2018

Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.

N Engl J Med 2018 Sep 26;379(12):1118-1127. Epub 2018 Aug 26.

From the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Feinstein Institute for Medical Research, and the Department of Medicine, Anticoagulation and Clinical Thrombosis Services, Northwell Health at Lenox Hill Hospital (A.C.S.), and the Cardiovascular Institute, Mount Sinai Medical Center (J.L.H.) - all in New York; the Department of Medicine and Surgery, University of Insubria, Varese, Italy (W.A.); the Stanford Stroke Center, Stanford University Medical Center, Stanford (G.W.A.), and the University of California at Davis, Sacramento (G.A.M.) - both in California; the Department of Medicine, Intermountain Medical Center, and Department of Medicine, University of Utah, Salt Lake City (C.G.E.); Division of Cardiology, University of Colorado School of Medicine, and CPC Clinical Research, Aurora (W.R.H.); Département Hospitalo-Universitaire FIRE (Fibrose Inflammation Remodelage), University Paris Diderot, Assistance Publique-Hôpitaux de Paris, and INSERM Unité 1148, Paris (P.G.S.); Imperial College, Royal Brompton Hospital, London (P.G.S.); McMaster University and the Thrombosis and Atherosclerosis Research Institute - both in Hamilton, ON, Canada (J.I.W.); Janssen Research and Development, Raritan (E.S., E.S.B.), and the Thrombosis and Hematology Therapeutic Area, Clinical Development, Pharmaceuticals, Bayer U.S., Whippany (T.E.S.) - both in New Jersey; and the College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City (G.E.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1805090DOI Listing
September 2018

Major Adverse Limb Events and 1-Year Outcomes After Peripheral Artery Revascularization.

J Am Coll Cardiol 2018 08;72(9):999-1011

Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado; CPC Clinical Research, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2018.06.041DOI Listing
August 2018

Antithrombotic Therapy for Peripheral Artery Disease in 2018.

JAMA 2018 Jun;319(22):2329-2330

Division of Cardiology, Department of Medicine, University of Colorado School of Medicine and CPC Clinical Research, Aurora.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2018.5422DOI Listing
June 2018

Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD).

Am Heart J 2018 05 3;199:83-91. Epub 2018 Feb 3.

CPC Clinical Research, Aurora, CO; University of Colorado School of Medicine, Division of Cardiology, University of Colorado Denver, Aurora, CO. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2018.01.011DOI Listing
May 2018

Response by Brass and Hiatt to Letter Regarding Article, "Aspirin Monotherapy Should Not Be Recommended for Cardioprotection in Patients With Symptomatic Peripheral Artery Disease".

Circulation 2018 03;137(12):1304

Department of Medicine, Division of Cardiology, University of Colorado School of Medicine and CPC Clinical Research, Aurora (W.R.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.117.032707DOI Listing
March 2018

PCSK9 Inhibitors: Mechanisms of Action, Metabolic Effects, and Clinical Outcomes.

Annu Rev Med 2018 01 2;69:133-145. Epub 2017 Nov 2.

Division of Cardiology and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1146/annurev-med-042716-091351DOI Listing
January 2018

Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial.

Eur J Vasc Endovasc Surg 2018 01 20;55(1):109-117. Epub 2017 Dec 20.

Department of Surgical Sciences, Section of Vascular Surgery, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejvs.2017.11.006DOI Listing
January 2018

Feasibility of Serial 6-min Walk Tests in Patients with Acute Heart Failure.

J Clin Med 2017 Sep 11;6(9). Epub 2017 Sep 11.

Department of Emergency Medicine & Indianapolis EMS, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm6090084DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615277PMC
September 2017

Aspirin Monotherapy Should Not Be Recommended for Cardioprotection in Patients With Symptomatic Peripheral Artery Disease.

Circulation 2017 08;136(9):785-786

From Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA (E.P.B.); and Department of Medicine, Division of Cardiology, University of Colorado School of Medicine and CPC Clinical Research, Aurora (W.R.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.117.028888DOI Listing
August 2017

Prognostic value of an increase in post-exercise ankle-brachial index.

Vasc Med 2017 06 1;22(3):204-209. Epub 2016 Dec 1.

3 Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1358863X16676902DOI Listing
June 2017

Response by Jones et al to Letter Regarding Article, "Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease".

Circulation 2017 06;135(23):e1109-e1110

From Duke Clinical Research Institute and Department of Medicine, Duke University Medical Center, Durham, NC (W.S.J., M.R.P.); and University of Colorado School of Medicine and CPC Clinical Research, Aurora (W.R.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.117.028199DOI Listing
June 2017

A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative.

Circulation 2017 Jun;135(25):2534-2555

From Department of Medicine, Division of Cardiology, University of Colorado School of Medicine, Aurora (C.N.H., W.R.H.); CPC Clinical Research, Aurora, CO (C.N.H., W.H.C., W.R.H.); Department of Surgery, Faculty of Medicine and Health, Örebro University, Sweden (L.N.); Ohio Health, Columbus (G.M.A.); Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Colorado School of Medicine, Aurora (W.H.C.); University of Sydney, Westmead Hospital, Australia (J.P.F.); Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, UK (F.G.R.F.); Department of Vascular Diseases, Lund University, Skåne University Hospital, Malmö, Sweden (A.G.); Department of Surgery, University of Sydney, Westmead Hospital, Australia (K.H.); Harvard Medical School, Boston, MA (M.R.J.); and Department of Vascular Surgery and Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska University Hospital and Academy, Gothenburg University, Sweden (J.N.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.117.024469DOI Listing
June 2017

The Treatment Gap in Peripheral Artery Disease.

J Am Coll Cardiol 2017 05;69(18):2301-2303

Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2017.03.024DOI Listing
May 2017

Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells).

Circulation 2017 Apr 16;135(15):1417-1428. Epub 2017 Feb 16.

From Texas Heart Institute (E.C.P., J.T.W., A.G., D.A.T., M.R., B.C., N.P.), CHI St. Luke's Health (R.M.), Houston; Indiana University School of Medicine, Indianapolis (M.P.M., K.L.M., P.G.); University of Louisville, KY (R.B., J.L., S.W.); Stanford University School of Medicine, CA (P.C.Y., N.J.L., R.L.D., F.K., E.G.R., M.R.S.); Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital, MN (J.A., J.H.T., J.G.); Cedars-Sinai Heart Institute, Los Angeles, CA (T.D.H.); University of Florida School of Medicine, Gainesville (C.J.P., R.D.A., S.B., D.L., E.H.); University of Minnesota Medical School, Minneapolis (G.R., B.B.-D., E.C., A.T.H.); University of Miami Miller School of Medicine, FL (O.V., J.M.H., I.H.S., D.D.); Orlando Health, FL (V.S.K.); University of Colorado School of Medicine and CPC Clinical Research, Aurora (W.R.H.); Johns Hopkins University, Baltimore, MD (B.A.- V., J.A.L.); Baylor College of Medicine, Houston, TX (A.P.G., A.G.D., J. Bloom, S.R.); University of Texas School of Public Health, Houston (J. Bettencourt, D.L., L.P., L.S., M.C., S.L.S., R.W.V., L.M.); National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD (R.F.E.); and University of Kansas School of Medicine, Kansas City (R.D.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.025707DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388585PMC
April 2017

Ticagrelor versus Clopidogrel in Peripheral Artery Disease.

N Engl J Med 2017 04;376(15):1488-9

University of Colorado School of Medicine and CPC Clinical Research, Aurora, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1701197DOI Listing
April 2017

Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease.

Circulation 2017 Jan 13;135(3):241-250. Epub 2016 Nov 13.

From Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (W.S.J., G.H., C.R., M.P.P.); Swiss Cardiovascular Centre, Inselspital, Bern University Hospital, University of Bern, Switzerland (I.B.); University of Colorado School of Medicine and CPC Clinical Research, Aurora (W.R.H.); Department of Surgery, University of California San Francisco (M.S.C.); Department of Cardiology, Ochsner Clinical School, University of Queensland, Australia (C.J.W.); Ochsner Medical Center, New Orleans, LA (C.J.W.); Departments of Medicine and Surgery, New York University School of Medicine (J.S.B.); AstraZeneca Gothenburg, Mölndal, Sweden (P.H., J.B., M.M.); AstraZeneca Gaithersburg, MD (B.G.K.); Stanford Center for Clinical Research, Stanford University School of Medicine, CA (K.W.M.); Faculty of Medicine and Health, Örebro University, Sweden (L.N.); and Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, UK (F.G.R.F.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.025880DOI Listing
January 2017

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.

N Engl J Med 2017 01 13;376(1):32-40. Epub 2016 Nov 13.

From the University of Colorado School of Medicine and CPC Clinical Research, Aurora (W.R.H.); Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh (F.G.R.F.); Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (G.H., W.S.J., C.R., M.R.P.); the Departments of Medicine and Surgery, New York University School of Medicine, New York (J.S.B.); Swiss Cardiovascular Center, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland (I.B.); AstraZeneca Gothenburg, Mölndal (P.H., J.B., M.M.), and Faculty of Medicine and Health, Örebro University, Örebro (L.N.) - both in Sweden; AstraZeneca Gaithersburg, Gaithersburg, MD (B.G.K.); and Stanford Center for Clinical Research, Stanford University School of Medicine, Stanford, CA (K.W.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1611688DOI Listing
January 2017

Nonatherosclerotic limb ischemia: Prompt evaluation and diagnosis.

Cleve Clin J Med 2016 Oct;83(10):741-751

Section of Vascular Surgery and Endovascular Therapy, Department of Surgery, University of Colorado, Aurora, CO, USA. E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3949/ccjm.83a.15102DOI Listing
October 2016

Finding Efficacy in a Safety Trial: Empagliflozin and Cardiovascular Death.

Circulation 2016 Sep;134(10):773-5

From Brigham and Women's Hospital, Divisions of Cardiovascular and Preventive Medicine, Boston, MA (B.M.E.); and University of Colorado School of Medicine, Aurora (W.R.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.024512DOI Listing
September 2016

Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillation.

Thromb Haemost 2016 08 23;116(3):544-53. Epub 2016 Jun 23.

John M. Kittelson, Ph.D., Historic Building 500, Box B119, University of Colorado Anschutz Medical Campus, 13001 East 17th Place, Aurora, CO 80045, USA, Tel.: +1 303 724 4364, E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH15-12-1000DOI Listing
August 2016

The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications.

Thromb Haemost 2016 06 4;115(6):1240-8. Epub 2016 Feb 4.

Gary E. Raskob, PhD, Dean, College of Public Health and Regents' Professor, Epidemiology and Medicine, University of Oklahoma Health Sciences Center, College of Public Health, 801 NE 13th Street, Oklahoma City, OK 73104, USA, Tel.: +1 405 271 2232, Fax: +1 405 271 3039, E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH15-09-0756DOI Listing
June 2016

The Development of Therapeutics for Peripheral Artery Disease: A Unique Cardiovascular Risk Population.

J Am Coll Cardiol 2016 06;67(23):2729-2731

Department of Medicine, Division of Cardiology, Section of Vascular Medicine and Intervention, University of Colorado School of Medicine, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2016.03.583DOI Listing
June 2016

Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations.

Circulation 2016 Jun;133(24):2459-502

From Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Colorado School of Medicine, Aurora (C.C.L.); CPC Clinical Research, Aurora, CO (C.C.L., C.N.H., W.R.H.); Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora (C.N.H., W.R.H.); Joslin Diabetes Center, and Harvard Medical School, Boston, MA (A.B.G.).

View Article

Download full-text PDF

Source
http://circ.ahajournals.org/content/circulationaha/133/24/24
Web Search
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.022194DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910510PMC
June 2016

Evaluating the Cardiovascular Safety of New Medications for Type 2 Diabetes: Time to Reassess?

Diabetes Care 2016 May;39(5):738-42

Division of Cardiology, University of Colorado School of Medicine, and CPC Clinical Research, Aurora, CO.

View Article

Download full-text PDF

Source
http://care.diabetesjournals.org/content/diacare/39/5/738.fu
Web Search
http://dx.doi.org/10.2337/dc15-2237DOI Listing
May 2016

Ankle-Brachial Index and cardiovascular events in atrial fibrillation. The ARAPACIS Study.

Thromb Haemost 2016 Apr 7;115(4):856-63. Epub 2016 Jan 7.

Prof. Francesco Violi, I Clinica Medica, Sapienza-University of Rome, Viale del Policlinico 155, Rome, 00161, Italy, Tel.: +39 06 4461933, Fax: +39 06 49970103, E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH15-07-0612DOI Listing
April 2016

Peripheral Artery Disease: Evolving Role of Exercise, Medical Therapy, and Endovascular Options.

J Am Coll Cardiol 2016 Mar;67(11):1338-57

Department of Medicine, Division of Cardiology, University of Colorado School of Medicine, and CPC Clinical Research, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2015.12.049DOI Listing
March 2016

Reducing LDL with PCSK9 Inhibitors--The Clinical Benefit of Lipid Drugs.

N Engl J Med 2015 Oct 7;373(17):1588-91. Epub 2015 Oct 7.

From Harvard Medical School and Divisions of Cardiovascular and Preventive Medicine, Department of Medicine, Brigham and Women's Hospital - both in Boston (B.M.E.); the Department of Medicine, Alpert Medical School, and the Department of Health Services, Policy, and Practice, School of Public Health, Brown University; and Ocean State Research Institute, Providence VA Medical Center - all in Providence, RI (R.J.S.); and the Department of Medicine, Division of Cardiology, University of Colorado School of Medicine, and CPC Clinical Research - both in Aurora (W.R.H.). All three authors participated as voting members of the FDA Endocrinologic and Metabolic Drugs Advisory Committee meeting on alirocumab, and Drs. Smith and Hiatt participated as voting members of the Advisory Committee meeting on evolocumab.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMp1508120DOI Listing
October 2015

Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation.

Am Heart J 2015 Sep 22;170(3):490-7.e1. Epub 2015 May 22.

I Clinica Medica, Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Umberto I Policlinico of Rome, Rome, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2015.05.011DOI Listing
September 2015

Community-based walking exercise for peripheral artery disease: An exploratory pilot study.

Vasc Med 2015 Aug 9;20(4):339-47. Epub 2015 Mar 9.

Division of General Internal Medicine, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA Center for Women's Health Research, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1358863X15572725DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749131PMC
August 2015

Cardiovascular Safety Outcome Trials: A meeting report from the Cardiac Safety Research Consortium.

Am Heart J 2015 Apr 15;169(4):486-95. Epub 2015 Jan 15.

Cardiology Center, University of Connecticut School of Medicine, Farmington, CT. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2015.01.007DOI Listing
April 2015

Pathogenesis of the limb manifestations and exercise limitations in peripheral artery disease.

Circ Res 2015 Apr;116(9):1527-39

From the Division of Cardiology, Department of Medicine (W.R.H., E.J.A.), CPC Clinical Research (W.R.H.), University of Colorado School of Medicine, Aurora; Cardiovascular & Metabolic Diseases Drug Discovery Unit, Takeda Pharmaceuticals, San Diego, CA (C.J.L.); and Department of Medicine, Harbor-UCLA Center for Clinical Pharmacology, Torrance, CA (E.P.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCRESAHA.116.303566DOI Listing
April 2015

Association between physical activity and peripheral artery disease and carotid artery stenosis in a self-referred population of 3 million adults.

Arterioscler Thromb Vasc Biol 2015 Jan 30;35(1):206-12. Epub 2014 Oct 30.

From the Division of Cardiology, Department of Medicine (R.A.S., J.S.B.), Division of Vascular Surgery, Department of Surgery (C.B.R., M.A.A., T.R., J.S.B.), Division of Biostatistics, Department of Population Health (Y.G.), New York University Langone Medical Center, New York; and Division of Cardiology, Department of Medicine, University of Colorado School of Medicine and CPC Clinical Research, Aurora (W.R.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.114.304161DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518860PMC
January 2015

Clinical trials in peripheral vascular disease: pipeline and trial designs: an evaluation of the ClinicalTrials.gov database.

Circulation 2014 Nov 19;130(20):1812-9. Epub 2014 Sep 19.

From the Duke Clinical Research Institute, Duke University, Durham, NC (S.S., M.R.P., K.C., B.A.T.-M., W.S.J., A.T., R.M.C.); North Carolina State University, Raleigh (B.A.T.-M.); University of California, San Francisco, San Francisco (M.S.C.); Ochsner Heart & Vascular Institute, New Orleans, LA (C.J.W.); Brigham and Women's Hospital and Harvard Medical School, Boston, MA (D.L.B.); University of California, Davis, Sacramento (J.R.L.); and University of Colorado School of Medicine and CPC Clinical Research, Aurora (W.R.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.114.011021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362518PMC
November 2014

Heart failure and peripheral artery disease: an unappreciated association.

Authors:
William R Hiatt

JACC Heart Fail 2014 Oct 3;2(5):455-6. Epub 2014 Sep 3.

Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2014.06.001DOI Listing
October 2014

Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population.

J Vasc Surg 2014 Sep 10;60(3):686-95.e2. Epub 2014 May 10.

Vascular Medicine Program, Lillehei Heart Institute and Cardiovascular Division, University of Minnesota Medical School, Minneapolis, Minn.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvs.2014.03.290DOI Listing
September 2014

Effect of tirasemtiv, a selective activator of the fast skeletal muscle troponin complex, in patients with peripheral artery disease.

Vasc Med 2014 Aug 28;19(4):297-306. Epub 2014 May 28.

Division of Cardiology, University of Colorado School of Medicine, Aurora, CO, USA CPC Clinical Research, Aurora, CO, USA

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1358863X14534516
Publisher Site
http://dx.doi.org/10.1177/1358863X14534516DOI Listing
August 2014

The treadmill is a better functional test than the 6-minute walk test in therapeutic trials of patients with peripheral artery disease.

Circulation 2014 Jul;130(1):69-78

From the University of Colorado School of Medicine, Department of Medicine, Division of Cardiology and CPC Clinical Research, Aurora (W.R.H., R.K.R.); and Harbor-UCLA Centers for Clinical Pharmacology, Torrance, CA (E.P.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.113.007003DOI Listing
July 2014

Response to McDermott.

Circulation 2014 Jul;130(1):68

View Article

Download full-text PDF

Source
July 2014

Sodium nitrite in patients with peripheral artery disease and diabetes mellitus: safety, walking distance and endothelial function.

Vasc Med 2014 Feb 20;19(1):9-17. Epub 2013 Dec 20.

Perelman School of Medicine at the University of Pennsylvania, Department of Medicine, Cardiovascular Division, Section of Vascular Medicine, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1358863X13515043
Publisher Site
http://dx.doi.org/10.1177/1358863X13515043DOI Listing
February 2014

Assessing the clinical benefits of lipid-disorder drugs.

N Engl J Med 2014 Jan;370(5):396-9

From the Division of Cardiology and CPC Clinical Research, Department of Medicine, University of Colorado School of Medicine, Aurora (W.R.H.); and the Alpert Medical School of Brown University and the Ocean State Research Institute, Providence Veterans Affairs Medical Center - both in Providence, RI (R.J.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMp1313866DOI Listing
January 2014

Community walking programs for treatment of peripheral artery disease.

J Vasc Surg 2013 Dec 5;58(6):1678-87. Epub 2013 Oct 5.

Division of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colo; Center for Women's Health Research, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colo. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvs.2013.08.034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904661PMC
December 2013

The cardiovascular safety of diabetes drugs--insights from the rosiglitazone experience.

N Engl J Med 2013 Oct 2;369(14):1285-7. Epub 2013 Sep 2.

Division of Cardiology and Colorado Prevention Center Clinical Research, Department of Medicine, University of Colorado School of Medicine, Aurora, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMp1309610DOI Listing
October 2013

Two new drugs for homozygous familial hypercholesterolemia: managing benefits and risks in a rare disorder.

JAMA Intern Med 2013 Sep;173(16):1491-2

Department of Medicine, Alpert Medical School of Brown University, Providence, Rhode Island2Ocean State Research Institute, Providence Veterans Administration Medical Center, Providence, Rhode Island.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamainternmed.2013.6624DOI Listing
September 2013

Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trial.

Endocr Pract 2013 Jan-Feb;19(1):19-28

Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Center Aurora, Colorado Diabetes Technology and Therapeutics University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://journals.aace.com/doi/abs/10.4158/EP12100.OR
Publisher Site
http://dx.doi.org/10.4158/EP12100.ORDOI Listing
August 2013

Association of clinical attributes and treadmill walking performance in patients with claudication due to peripheral artery disease.

J Vasc Surg 2013 Aug 16;58(2):396-403. Epub 2013 May 16.

Harbor-University of California Los Angeles (UCLA) Center for Clinical Pharmacology, Torrance, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvs.2012.12.077DOI Listing
August 2013

Should an alternate ABI definition be adopted to evaluate risk?

Authors:
William R Hiatt

J Am Coll Cardiol 2013 Aug 22;62(6):560-1. Epub 2013 May 22.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2013.04.056DOI Listing
August 2013

Vascular disease: vorapaxar prevents progression of peripheral artery disease.

Authors:
William R Hiatt

Nat Rev Cardiol 2013 Jul 30;10(7):367-8. Epub 2013 Apr 30.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrcardio.2013.66DOI Listing
July 2013

Omega-3 fatty acids for intermittent claudication.

Cochrane Database Syst Rev 2013 Jul 4(7):CD003833. Epub 2013 Jul 4.

College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD003833.pub4DOI Listing
July 2013

Proceedings from the Society of Interventional Radiology research consensus panel on critical limb ischemia.

J Vasc Interv Radiol 2013 Apr;24(4):451-8

Department of Radiology, Division of Vascular and Interventional Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvir.2012.10.028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940238PMC
April 2013

A systematic review and meta-analysis of propionyl-L-carnitine effects on exercise performance in patients with claudication.

Vasc Med 2013 Feb 15;18(1):3-12. Epub 2013 Jan 15.

Harbor-UCLA Center for Clinical Pharmacology, Torrance, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1358863X12467491DOI Listing
February 2013

Antiplatelet therapy in peripheral artery disease.

Handb Exp Pharmacol 2012 (210):547-63

Prima Clinica Medica, Sapienza-University of Rome, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-642-29423-5_22DOI Listing
January 2013

A validated biomarker panel to identify peripheral artery disease.

Vasc Med 2012 Dec 19;17(6):386-93. Epub 2012 Oct 19.

University of Colorado School of Medicine, Division of Cardiology, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1358863X12463491DOI Listing
December 2012

Cardiovascular risk assessment in the development of new drugs for obesity.

JAMA 2012 Sep;308(11):1099-100

University of Colorado School of Medicine, Division of Cardiology and CPC Clinical Research, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2012.9931DOI Listing
September 2012

Proarrhythmic potential of dronedarone: emerging evidence from spontaneous adverse event reporting.

Pharmacotherapy 2012 Aug 28;32(8):767-71. Epub 2012 Jun 28.

Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/j.1875-9114.2012.01118.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463717PMC
August 2012

Medical therapy in peripheral artery disease.

Circulation 2012 Jul;126(4):491-500

Divisions of Cardiology and Vascular Surgery, New York University School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.111.033886DOI Listing
July 2012

L-Carnitine plus cilostazol versus cilostazol alone for the treatment of claudication in patients with peripheral artery disease: a multicenter, randomized, double-blind, placebo-controlled trial.

Vasc Med 2012 Jun;17(3):145-54

Department of Medicine, Division of Hematology, University of Colorado School of Medicine, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1358863X12442264DOI Listing
June 2012

Aspirin in primary prevention: can we individualize care?

Cardiovasc Diagn Ther 2012 Jun;2(2):169-72

Department of Medicine, Leon Charney Division of Cardiology, New York University School of Medicine, New York, NY 10016;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2223-3652.2012.04.02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839141PMC
June 2012

What cost weight loss?

Circulation 2012 Mar;125(9):1171-7

Department of Medicine, Division of Cardiology, University of Colorado School of Medicine and, CPC Clinical Research, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.111.023499DOI Listing
March 2012

A phase II dose-ranging study of the phosphodiesterase inhibitor K-134 in patients with peripheral artery disease and claudication.

J Vasc Surg 2012 Feb 25;55(2):381-389.e1. Epub 2011 Nov 25.

Harbor-UCLA Center for Clinical Pharmacology, Torrance, CA 90502, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S074152141102081
Publisher Site
http://dx.doi.org/10.1016/j.jvs.2011.09.004DOI Listing
February 2012

Progression of asymptomatic peripheral artery disease over 1 year.

Vasc Med 2012 Feb;17(1):10-6

Department of Medicine, Cardiovascular Division, Section of Vascular Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1358863X11431106DOI Listing
February 2012